AG-120 in People With IDH1 Mutant Chondrosarcoma
NCT04278781
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Chondrosarcoma
Chondrosarcoma, Grade 2
Chondrosarcoma, Grade 3
IDH1 Gene Mutation
Interventions
DRUG:
AG-120
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]